image
NewAmsterdam Pharma Company N.V. NAMS
Healthcare - Biotechnology - NASDAQ - NL
Watchlist
$ 16.79
-0.49 %
$ 1.84 B
Market Cap
-6.35
P/E
Price Target Average
146.58%
Revenue Forecast Estimate
93.25%
EBIT Estimate
60.25%
Net Income Estimate
27.16%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets NewAmsterdam Pharma Company N.V.
image
Wall Street analysts predict an average 1-year price target for NAMS of $41.4 , with forecasts ranging from a low of $36 to a high of $48 .
NAMS Lowest Price Target Wall Street Target
36 USD 114.41%
NAMS Average Price Target Wall Street Target
41.4 USD 146.58%
NAMS Highest Price Target Wall Street Target
48 USD 185.88%
Price
Max Price Target
Min Price Target
Average Price Target
505045454040353530302525202015151010Jun '24Jun '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart NAMS

image
$700.0m$700.0m$600.0m$600.0m$500.0m$500.0m$400.0m$400.0m$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.02022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart NAMS

image
$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)2022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart NAMS

image
$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)2022202220232023202420242025202520262026202720272028202820292029